The FDA has approved the Phase II trial for the evaluation of the Drug-Eluting Bead delivering irinotecan in patients with hepatic colo-rectal metastases.
References and Resources
FDA.gov
Sponsored by The Doctor’s Channel
The FDA has approved the Phase II trial for the evaluation of the Drug-Eluting Bead delivering irinotecan in patients with hepatic colo-rectal metastases.
References and Resources
FDA.gov
Sponsored by The Doctor’s Channel
